SF3B4 was either silenced or overexpressed in HCC cell lines, followed by full-length transcriptome sequencing via Oxford Nanopore Technology to analyze global transcriptional and alternative splicing changes. Here, SF3B4 is linked to hepatocellular carcinoma.